YourScout

Your personal agent,
finding your next opportunity.

You describe what you're looking for once. Every night YourScout works sources that listings never reach, and each morning your dashboard holds the few leads worth your time — scored, sourced, and drafted.

Join early access See how it works

It finds and prepares; you decide and send. Nothing goes out without you.

New inbox 1 opportunity
Verrothen Biosciences Fit 4.7
Rare disease genomicsSeries B, 2024Cambridge, MA

FundingAnnounced a data-sharing partnership with two academic medical centers. Their computational biology team is hiring a principal scientist role that overlaps your brief.

Why it fits

A newly funded team needs the exact computational biology and patient-data experience in your brief. CEO Lyra Droshen has co-authored with two of your former collaborators.

➤ Send email ✓ Mark sent ✕ Not a fit
Dossier · 4 sources · contact verifiedⓘ why this lead

Found, checked, drafted. Never sent without you.

Runs nightlyScored 1–5, counterevidence includedDraft attached to every lead

How it works

You sleep.
It searches.

No feeds to tune and no alerts to triage. You give it a brief; it gives you back a short morning list with the work already done.

  1. 01

    Understand what fits

    Your goals, experience, constraints, and preferences become a living search brief — not a bag of keywords.

    scout-brief.mdUpdated today

    "Find work where computational biology, patient impact, and an unusual path to influence overlap. Preference for smaller teams with recent funding and a translational research focus."

    7 active scoutsLast run 14m ago
  2. 02

    Scout beyond the obvious

    It follows weak signals across companies, funding, research, hiring, partnerships, and people.

    03:12Scanned 214 new funding announcements
    03:18Cross-referenced 38 hiring signals
    03:24Found 3 leads above brief threshold
    03:41Evidence checked, dossiers prepared
    03:42Drafts ready. Inbox updated.
  3. 03

    Bring back what matters

    Each finding includes the evidence, counterevidence, timing, and a practical next move.

    Pallmark Diagnostics Fit 3.9
    Point-of-care testingSeed, 2025

    HiringLooking for a data platform lead. Small team, strong overlap with your device-validation background.

    ➤ Send email view draft ✕ Not a fit

The dashboard

Every morning,
the whole picture.

Every recommendation shows why it fits and what could make it wrong. Evidence, timing, contact path, and a prepared draft — ready when you are.

app.yourscout.io Updated 14m ago
Send now1
New3
Sent12
Follow-ups due2
Action items today2
New — best first3 leads
Verrothen Biosciences Fit 4.7 SEND NOW
Rare disease genomicsSeries B, 2024Cambridge, MA

FundingData-sharing partnership announced. Hiring a principal scientist. CEO Lyra Droshen co-authored with two of your former collaborators.

ⓘ why this lead · company & contact intel

Founded 2021, 34 employees. $28M Series B led by Atlas Venture. Three NIH SBIR grants. Lead program in inherited retinal dystrophies. Published 12 peer-reviewed papers in the last 18 months. Two board members overlap with your network.

➤ Send email view draft ✓ Mark sent ✕ Not a fit
Pallmark Diagnostics Fit 3.9
Point-of-care testingSeed, 2025Portland, ORdraft ready

HiringData platform lead role. Small team, strong overlap with your device-validation background.

➤ Send email view draft ✕ Not a fit
Kethane Bio Fit 3.1
Agricultural biotechSeries A, 2023

ResearchPublished a pre-print on CRISPR-based trait screening that cites your 2022 methods paper.

view draft ✕ Not a fit
Follow-upsWaiting on replies

RepliedTunvale Health — Lydia Orren responded to your intro. Suggested a 20-minute call next week.

View thread

Brellica Dx — Outreach sent 4 days ago. No reply yet. Follow-up draft ready.

Send follow-up

What you get

Fewer leads.
Better reasons.

YourScout is built to make a judgment, not inflate a count. A quiet day with nothing worth sending beats a day of padded, low-signal noise.

Early access

Let YourScout
find it.

Join early access

A short email gets you into the first group. No list, no drip campaign.